Nuwellis Inc (NUWE) posted a Q4 2025 GAAP loss of $1.50 per share. The company generated $2.42M in revenue for the quarter.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure.
The medical device maker is based in Eden Prairie, Minnesota and trades on the NASDAQ exchange.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.